Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin

MA Curran, TL Geiger, W Montalvo, M Kim… - Journal of Experimental …, 2013 - rupress.org
4-1BB agonist antibody treatment induces a population of KLRG1+ T cells that infiltrate
melanoma tumors. We investigated the origin and function of these cells, as well as their …

[HTML][HTML] Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin

MA Curran, TL Geiger, W Montalvo, M Kim… - The Journal of …, 2013 - ncbi.nlm.nih.gov
1BB agonist antibody treatment induces a population of KLRG1+ T cells that infiltrate
melanoma tumors. We investigated the origin and function of these cells, as well as their …

Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin

MA Curran, TL Geiger, W Montalvo… - The Journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
4-1BB agonist antibody treatment induces a population of KLRG1 (+) T cells that infiltrate
melanoma tumors. We investigated the origin and function of these cells, as well as their …

Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of eomesodermin

MA Curran, TL Geiger… - Journal of …, 2013 - mdanderson.elsevierpure.com
1BB agonist antibody treatment induces a population of KLRG1+ T cells that infiltrate
melanoma tumors. We investigated the origin and function of these cells, as well as their …

[PDF][PDF] Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin

MA Curran, TL Geiger, W Montalvo, M Kim… - J. Exp …, 2013 - pdfs.semanticscholar.org
RESULTS Tumor-infiltrating KLRG1+ T cells elicited by 4-1BB agonist antibody treatment
express a broad spectrum of cytotoxicity-associated genes Previously we have shown that …

Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin

MA Curran, TL Geiger, W Montalvo… - Journal of …, 2013 - eprints.soton.ac.uk
4-1BB agonist antibody treatment induces a population of KLRG1+ T cells that infiltrate
melanoma tumors. We investigated the origin and function of these cells, as well as their …

Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin.

MA Curran, TL Geiger, W Montalvo, M Kim… - The Journal of …, 2013 - europepmc.org
1BB agonist antibody treatment induces a population of KLRG1+ T cells that infiltrate
melanoma tumors. We investigated the origin and function of these cells, as well as their …

[PDF][PDF] Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin

MA Curran, TL Geiger, W Montalvo, M Kim… - J. Exp …, 2013 - scienceopen.com
RESULTS Tumor-infiltrating KLRG1+ T cells elicited by 4-1BB agonist antibody treatment
express a broad spectrum of cytotoxicity-associated genes Previously we have shown that …

Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin

MA Curran, TL Geiger, W Montalvo, M Kim… - Journal of Experimental …, 2013 - cir.nii.ac.jp
抄録< jats: p> 4-1BB agonist antibody treatment induces a population of KLRG1+ T cells that
infiltrate melanoma tumors. We investigated the origin and function of these cells, as well as …

[PDF][PDF] Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin

MA Curran, TL Geiger, W Montalvo, M Kim… - J. Exp. Med, 2013 - researchgate.net
RESULTS Tumor-infiltrating KLRG1+ T cells elicited by 4-1BB agonist antibody treatment
express a broad spectrum of cytotoxicity-associated genes Previously we have shown that …